We are live on
!
Find out more
Orbis Allan Gray Portfolio holdings
AUM
$29.1B
Turnover
17.48%
1-Year Est. Return
60.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.76%
1 Year Est. Return
+60.8%
3 Year Est. Return
+154.65%
5 Year Est. Return
+203.47%
10 Year Est. Return
+909.03%
AUM
$23.7B
AUM Growth
-$160M
(-0.67%)
Cap. Flow
-$426M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
37.81%
Holding
99
New
10
Increased
43
Reduced
34
Closed
8
Avg Time Held
2.4
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQT Corp
EQT
|
+$506M |
| 2 |
Nebius Group N.V.
NBIS
|
+$497M |
| 3 |
NVIDIA
NVDA
|
+$383M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$377M |
| 5 |
FirstService
FSV
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$852M |
| 2 |
Icon
ICLR
|
+$768M |
| 3 |
Insmed
INSM
|
+$355M |
| 4 |
Elevance Health
ELV
|
+$349M |
| 5 |
Fortune Brands Innovations
FBIN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.49% |
| 2 | Healthcare | 16.12% |
| 3 | Communication Services | 13.22% |
| 4 | Technology | 12.46% |
| 5 | Materials | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
NVIDIA
NVDA
$5.27T
| $364M | 1.54% |
+2,089,904
| New | +$383M |
2026 Q1
0 quarters
|
|
27
Walt Disney
DIS
$193B
| $360M | 1.52% |
3,734,888
+171,838
| +5% | +$18.2M |
2023 Q3
10 quarters
|
|
28
Genmab
GMAB
$23.2B
| $347M | 1.46% |
12,925,578
-1,492,884
| -10% | -$44.7M |
2024 Q3
6 quarters
|
|
29
Booking.com
BKNG
$124B
| $311M | 1.31% |
1,844,300
+1,075,600
| +140% | +$198M |
2023 Q2
11 quarters
|
|
30
Vale
VALE
$55.8B
| $308M | 1.3% |
19,372,500
+1,130,319
| +6% | +$17.6M |
2024 Q4
5 quarters
|
|
|
31
Insmed
INSM
$21.2B
| $306M | 1.29% |
1,872,824
-2,307,133
| -55% | -$355M |
2025 Q2
3 quarters
|
|
32
CRISPR Therapeutics
CRSP
$4.91B
| $290M | 1.23% |
6,106,011
+155,866
| +3% | +$8.22M |
2024 Q4
5 quarters
|
|
33
Diageo
DEO
$52.6B
| $275M | 1.16% |
3,700,094
+1,962,748
| +113% | +$171M |
2025 Q1
4 quarters
|
|
34
Franco-Nevada
FNV
$47.4B
| $267M | 1.12% |
1,079,439
-329,750
| -23% | -$81.6M |
2024 Q1
8 quarters
|
|
35
Barrick Mining
B
$67.7B
| $246M | 1.04% |
6,020,532
-661,668
| -10% | -$30.6M |
2016 Q1
40 quarters
|
|
36
Antero Resources
AR
$11.5B
| $207M | 0.87% |
4,872,046
+4,127,938
| +555% | +$151M |
2025 Q4
1 quarter
|
|
37
Scholar Rock
SRRK
$4.82B
| $205M | 0.87% |
4,179,983
+751,054
| +22% | +$33.7M |
2025 Q3
2 quarters
|
|
38
SPDR Gold Trust
GLD
$142B
| $204M | 0.86% |
473,850
-49,936
| -10% | -$22.4M |
2016 Q1
40 quarters
|
|
39
BBB Foods
TBBB
$6.9B
| $200M | 0.84% |
5,646,435
+2,357,712
| +72% | +$82.5M |
2025 Q4
1 quarter
|
|
40
IMAX
IMAX
$2.86B
| $196M | 0.83% |
5,151,721
| – | – |
2024 Q2
7 quarters
|
|
41
RenaissanceRe
RNR
$14.4B
| $193M | 0.81% |
648,479
+13,542
| +2% | +$3.93M |
2025 Q4
1 quarter
|
|
42
Robert Half
RHI
$3.46B
| $192M | 0.81% |
+7,545,564
| New | +$200M |
2026 Q1
0 quarters
|
|
43
Pinduoduo
PDD
$117B
| $178M | 0.75% |
1,744,048
+575,721
| +49% | +$60.5M |
2024 Q4
5 quarters
|
|
44
AES
AES
$10.7B
| $173M | 0.73% |
12,247,581
-9,069,753
| -43% | -$135M |
2020 Q3
22 quarters
|
|
45
Sea Limited
SE
$58.6B
| $153M | 0.64% |
1,844,162
-871,693
| -32% | -$93.4M |
2024 Q3
6 quarters
|
|
46
California Resources
CRC
$4.75B
| $151M | 0.64% |
2,177,565
+250,796
| +13% | +$14.2M |
2020 Q4
21 quarters
|
|
47
Ryder
R
$9.24B
| $146M | 0.61% |
711,714
-262,906
| -27% | -$53.2M |
2024 Q3
6 quarters
|
|
48
Brinker International
EAT
$8.61B
| $132M | 0.56% |
+927,512
| New | +$141M |
2026 Q1
0 quarters
|
|
49
Dyne Therapeutics
DYN
$2.76B
| $123M | 0.52% |
6,762,231
+1,960,303
| +41% | +$33.8M |
2025 Q4
1 quarter
|
|
50
Range Resources
RRC
$9.86B
| $122M | 0.52% |
+2,706,746
| New | +$106M |
2026 Q1
0 quarters
|
|
Similar funds
Orbis Allan Gray's Q1 2026 Portfolio in Review
As of Q1 2026, Orbis Allan Gray held 99 positions worth $23.7B, down 0.67% from $23.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Orbis Allan Gray's Q1 2026 filing shows 10 new, 43 increased, 34 reduced and 8 closed positions. Its largest new stake was NVIDIA: 2,089,904 shares worth $364M. The largest sale was UnitedHealth, an estimated $852M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Communication Services.
- Orbis Allan Gray's largest Q1 2026 buy was NVIDIA: 2,089,904 shares worth $364M.
- Orbis Allan Gray added most to EQT Corp in Q1 2026, an estimated $506M increase.
- Orbis Allan Gray's biggest Q1 2026 reduction was Insmed, cutting an estimated $355M.
- Orbis Allan Gray fully exited UnitedHealth in Q1 2026, selling an estimated $852M.
- Orbis Allan Gray's ten largest holdings make up 38% of its $23.7B portfolio in Q1 2026.
- Orbis Allan Gray opened 10 new positions and closed 8 in Q1 2026.
- Orbis Allan Gray's portfolio value fell 0.67% quarter-over-quarter to $23.7B.
Based on Orbis Allan Gray's 13F filing for Q1 2026, filed 15 May 2026.